LPL Financial
EW icon

LPL Financial’s Edwards Lifesciences EW Stock Holding History

LPL Financial’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-3,000
Closed -$256K – 6041
2025
Q4 		$256K Hold
3,000
– – ﹤0.01% 5272
2025
Q3 		$233K Sell
3,000
-2,000
-40% -$156K ﹤0.01% 5237
2025
Q2 		$391K Buy
+5,000
New +$373K ﹤0.01% 4575

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

LPL Financial's EW Position: Q1 2026 in Review

LPL Financial increased its Edwards Lifesciences (EW) stake by 51% in Q1 2026, buying an estimated $9.87M and bringing the position to 353,591 shares worth $28.3M. The position accounts for 0.01% of the portfolio, ranked #1242.

LPL Financial first reported a position in EW in Q3 2013 and has held it in 51 quarters since. The position peaked at $37M in Q4 2021. 1,284 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • LPL Financial held 353,591 shares of Edwards Lifesciences worth $28.3M as of Q1 2026.
  • LPL Financial bought 119,756 Edwards Lifesciences shares in Q1 2026, an estimated $9.87M.
  • Edwards Lifesciences made up 0.01% of LPL Financial's portfolio in Q1 2026, its #1242 holding.
  • LPL Financial first reported a position in Edwards Lifesciences in Q3 2013 and has held it in 51 quarters since.
  • LPL Financial's Edwards Lifesciences position peaked at $37M in Q4 2021.
  • 1,284 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on LPL Financial's 13F filing for Q1 2026, filed 6 May 2026.